ClearPoint Neuro wins FDA clearance for neuro laser accessory
ClearPoint Neuro (Nasdaq:CLPT) announced today that the FDA granted 510(k) clearance for its Prism bone anchor accessory.
Stay updated with breaking news from Chris Osswald. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ClearPoint Neuro (Nasdaq:CLPT) announced today that the FDA granted 510(k) clearance for its Prism bone anchor accessory.
ClearPoint Neuro (Nasdaq:CLPT) today announced preclinical results highlighting the accuracy of its Prism neuro laser therapy system.
SOLANA BEACH, Calif., March 11, 2024 -- ClearPoint Neuro, Inc. , a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that...
SOLANA BEACH, Calif., Jan. 24, 2024 -- ClearPoint Neuro, Inc. , a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced...
ClearPoint Neuro (Nasdaq:CLPT) announced that it completed the first procedures with its laser therapy and navigation systems.